Eco-labels impact consumers‟ likelihood to buy eco-labelled products and serve as a tool during the decision-making process that helps consumers make informed purchase choices. The textile industry is responsible for a large amount of pollution, but has started to follow a more holistic, eco-friendly approach. Information about their eco-friendliness is communicated to consumers via eco-labels. Consumers can influence the textile industry to include more eco-labelled textile products in their desired range of products, by buying and demanding eco-labelled textile products. However, international studies indicate that consumers do not understand textile eco-labels and the information that is found on these labels. A lack of understanding prevents consumers from including such products in their pre-purchase decision-making process. Yet some consumers, from developed and developing countries, are willing to buy eco-labelled products and pay more for such products. Limited research in this regard, within a South African context, is available hence, more research was required in this study field. Therefore, this study aimed to explore consumers‟ understanding and utilisation of textile eco-labels during pre-purchase decision-making. The research for the study was done using a convenience and purposive sampling method with a quantitative structured online questionnaire for data collection purposes. Findings suggest that respondents were environmentally conscious, but only to some extent. Most respondents objectively understood textile eco-labelled products, but not textile eco-labels or organic label information regarding cotton production processes. Respondents indicated that they do not use textile eco-labels when making a pre-purchase decision, yet they somewhat recognised the need to buy eco-friendly textile products, because they are aware of environmental implications. Regarding the information on eco-labels, respondents searched for information surrounding the quality of eco-labelled textile products, followed by the care instructions and the credibility of the eco-label on the product. Finally, there was a segment of respondents who buy and utilise textile eco-labelled products, and are willing to pay a higher price for these products. The higher price was the main factor that prevented other respondents from buying eco-labelled textile products. Consumers can benefit from education regarding environmental issues and how their purchasing choices can make a difference in protecting the environment. Furthermore, educating consumers about eco-labelled textile products might increase their awareness and utilisation of these products. In turn, this awareness about eco-labels might encourage consumers to include these kinds of products in their pre-purchase decision-making process. Additionally the industry can strive towards keeping eco-labelled products‟ prices relatively equal to regular product‟s prices to make it easier for consumers to choose between the different products, based on their environmental attributes and not price. Finally, the textile industry and manufacturers can focus on making textile eco-labels more attractive and attention-grabbing in order to focus consumers‟ attention on these labels. Furthermore, on these labels, symbols and words should be used together and all elements should correspond to enhance consumers‟ understanding. If all of these elements of an eco-label convey the same message, consumers might be able to understand the intended message by manufacturers and the industry better. / M Consumer Sciences, North-West University, Potchefstroom Campus, 2014

More people living with HIV/AIDS reside in South Africa than any other country in the world, and the nation faces colossal challenges in broadening its response to the now-mature and widespread HIV epidemic (WHO, 2005:1). According to South Africa's Medical Research Council, HIV/AIDS has now become the single largest cause of death in South Africa (Dorrington et a/., 2001:6) and has triggered a prominent transferal in the pattern of mortality from the elderly to the young, particularly among young women (Dorrington, 2001:4). The routine treatment of HIV/AIDS with antiretroviral drugs has transformed HIV-infection from an unvaryingly rapidly terminal illness to a somewhat expensive treatable, chronic disease. Triple therapy or highly active antiretroviral therapy (three-drug combinations of ARVs or HAART) in particular have had paramount impacts on HIV-related morbidity and mortality in settings where these drugs are generally accessible. Objectives of ARV treatment are "maximum, durable suppression of viral load, restoration and/or preservation of immune function, improvement of quality of life and reduction of HIV related morbidity and mortality" (Martinson et a/., 2003:236; Martinez et a/., 2007:251; Hellinger, 2006:1; Kumarasamy, 2004:3). The Joint United Nations Programme on HIV/AIDS (UNAIDS) estimated that a total of 111 827 South Africans were accessing free antiretroviral treatment in the 200 public health sector facilities across 53 districts and a further 60 000 via the private sector by late December 2005 (UNAIDS, 2005:1). The objective of this study was to review, analyse and interpret the usage and prescribing patterns of antiretroviral drugs in a section of the South African private health care sector for the period 1 January 2005 to 31 December 2006 by utilising a medicine claims database of a pharmacy benefit management company, and to investigate the costs associated with these drugs by performing a quantitative, retrospective drug utilisation review. It was found that the prevalence as well as the total medicine cost of ARV medicine items had increased during the study period but the average number of ARV medicine items per prescription as well as both the average cost per ARV medicine item and the average cost per ARV prescription decreased during the study period. Original innovator ARV medicine items and original ARV medicine items with no generic were found to be relatively expensive in comparison with ARV medicine items in general. Conversely, generic ARV medicine items were ascertained to be relatively inexpensive with reference to ARV medicine items in general. It was perceived that the average cost of ARV medicine items and prescriptions for both genders decreased from 2005 to 2006, while there was an increase in the prevalence of medicine items and prescriptions claimed for both female and male patients. The prevalence and cost of all types of ARV medicine items were found to be higher for female patients in general. It was also established that the prevalence of patients receiving antiretroviral treatment in the private health care sector peaks at the age of >30 to 244 years, in comparison with the lower age of >25 to 239 years in the public health care sector. ARV medicine items claimed for patients in the age group >35 to 239 years represented the highest percentage of the total medicine cost incurred during both study years for all ARV medicine types. The majority of ARV medicine items were prescribed by general medical practitioners, and most ARV medicine items were dispensed by community or private institutional pharmacies. It was determined that combinations of 2NRTI + NNRTI were prescribed with the highest frequency, which is compliant with traditional HAART or 'triple therapy' regimens. Lastly, it was found that none of the top 20 prescriptions for one, two and six ARV medicine items were compliant with the National Antiretroviral Treatment (ART) Guidelines. The majority of the top 20 prescriptions for three ARV medicine items (92.67 per cent during 2005 and 89.94 per cent during 2006) were compliant with the National ART Guidelines. Finally, less than half of the top 20 prescriptions for four ARV medicine items (49.60 per cent during 2005 and 36.11 per cent during 2006) were compliant with the National ART Guidelines. Only 5.56 per cent and 3.92 per cent of the top 16 prescriptions for five ARV medicine items were compliant with the National ART Guidelines during the two study years respectively / Thesis (M. Pharm. (Pharmacy Practice))--North-West University, Potchefstroom Campus, 2009.

Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for systemic control of acute and chronic pain and inflammation (Lin et ah, 2000:1129), but usage problems and side-effects that occur during the post-marketing phase of these drugs are well documented (Thiefin & Beaugerie, 2005:287). Following the demonstration of the value of anti-inflammatory therapy in diseases like rheumatoid arthritis (Boardman & Dudley Hart, 1967:268), new NSAIDs appeared on the market (Dieppe et al., 2004:867), and the indications steadily broadened from inflammatory diseases to almost any painful condition. Studies have indicated that NSAID-associated serious upper gastro-intestinal (GI) adverse events result in 103 000 hospitalisations (Bombardier, 2002:4) and 165 000 deaths per year in the United States. A study in South Africa in 2002 indicated that NSAID utilisation contributed considerably to the total cost of all medicine items from a medicine claim database in the private health care sector (Joubert, 2002:260). The objective of this study was to determine the prevalence and cost of non-steroid anti-inflammatory drugs in a section of the private health care sector, and specifically to determine the prevalence, usage and cost of Coxib (Specific cyclo-oxygenase-2 inhibitor) medicine items before and after the withdrawal of Vioxx® from the market in September 2004 (Merck, 2004). Data from two medicine claim databases for the years 2004, 2005 and 2006 (medicine claim database I) and the years 2005 and 2006 (medicine claim database M), were analysed by means of a retrospective drug utilisation review (DUR) study. The usage of Coxib medicine items was determined, and compared for the periods before and after the withdrawal of Vioxx® in September 2004. It was found that between 9 and 10.5 per cent of prescriptions dispensed through both medicine claim database I and medicine claim database M during the study period were NSAID prescriptions. NSAID medicine items on medicine claim database I represented between 3.9 % (R25 942 986) and 2.9 % (R8 073 034) of the total cost of all medicine items claimed from 2004 to 2006. NSAIDs represented 3.1 % (R58 290 412) and 2.8 % (R57 752 267) of the cost of all medicine items claimed through medicine claim database M during 2005 and 2006 respectively, indicating similar trends in the two medicine claim databases. The prevalence of Coxibs on medicine claim database I decreased from almost 20 % (47 938) in 2004 to 8.4 % (13 276) in 2005, but showed an increase again to 10.9 % (12 355) in 2006. The prevalence of both cyclo-oxygenase (COX) inhibitors, and Coxibs demonstrated a change during 1 September 2004 to 31 December 2004 when COX-inhibitors showed an increase in use, while Coxibs showed and almost equal but opposite trend with a decrease in use. This could possibly be related to perceptions of providers and public with regard to Coxibs and their related safety after the withdrawal of Vioxx® on 30 September 2004 (Merck, 2004) and other Coxibs such as Bextra® (FDA, 2005) in 2005 in USA. It is concluded that most patients who were using Coxibs before the withdrawal of Vioxx®, substituted Coxibs for COX-inhibitors, that are known for their possible gastro-intestinal side-effects. Recommendations for future research regarding NSAID use were also made, and included an investigation of the usage of Coxibs in different age groups, as well as the combination of NSAIDs with gastro-protective medicines in long-term use. / Thesis (M.Pharm. (Pharmacy Practice))--North-West University, Potchefstroom Campus, 2009.

THE UTILISATION OF LIFE MAPS AS AN AID IN FOSTER CARE SERVICE DELIVERY. During the past few years there has been a significant increase in foster care service delivery, partially due to the HIV and AIDS pandemic. More children need to be placed in foster care, and family placements become an only option in many cases. Due to this shift in foster care placements permanency planning has become an important part of foster care services. Thus, this study has focused on the development of guidelines by using a concept model with the focus on life maps in order to facilitate and structure the foster care process. / Thesis (M.A. (MW))--North-West University, Potchefstroom Campus, 2009.

This study focuses on optimising operations effectiveness and capacity at a heavy engineering plant, namely Heavy Engineering Vereeniging, a division of DCD–DORBYL (Pty) Ltd. The implementation and adoption of technology was included in the investigation. The company operates from 2 premises in Vereeniging and Vanderbijlpark (Gauteng), and consists of 5 factory buildings. A literature review was conducted to ascertain current industry best practises and technology implementation initiatives. This review included a discussion on the following aspects: Capacity and its utilisation, flexible technology and advanced manufacturing systems, technology in manufacturing, capacity expansion and scheduling, factory layouts, technology and capacity utilisation in a South African context, and finally future trends in capacity and technology at Heavy Engineering Vereeniging. Data collection from within the organisation was done via the issuing of a questionnaire and conducting interviews with various management and supervision employees. The gathered data was analysed for employees’ opinions on current utilisation of capacity and use of technology, as well as suggestions regarding improved working methods, factory layout and the implementation of new technology. The quantitative data was analysed using the Statistical Package for the Social Sciences software, with the provided descriptive statistical test results used for the identification of possible trends and further interpretation. It was found that current capacities and equipment are being well utilised, but not to their optimal level. The well entrenched management information systems, measurement systems and operating procedures currently in use will aid to increase the level of utilisation of the available capacity and equipment. The implementation of technology and latest best practises within the operation will gain HEV a competitive edge, ensuring their future sustainability and market leadership. However, this implementation must be done with the input and buy in of the work force. The variances in perceptions and attitudes between the various job functions, discovered during the statistical analysis, must be taken into cognisance during any capacity optimisation or technology implementation initiative. Continued capital expenditure and the current drives in research and development need to be maintained to further ensure sustainability. Various inefficiencies were identified and recommendations were made to improve the current operation’s effectiveness and factory layout, primarily by decreasing operating inefficiencies. The recommendations were made based on the results of the study and included the expenditure involved in their execution. Financially viable options, calculated using payback periods and net present values (NPV), included the purchase of phased array ultrasonic testing equipment, horizontal SAW for longitudinal flanges and a modular type furnace. Other options, which could improve operations effectiveness, but not returning financially positive results, included the moving of the Hausler roll into the main fabrication workshop and the moving of the Sachems drills to alongside the lathes. A number of new processes and initiatives were recommended, for which cost comparisons to current similar practices could not be performed. These included the full production implementation of the punch through tandem arc submerged arc welding for wind turbine tower manufacture, implementation of a customer interfacing and communication platform and internal communication display boards. Current practises regarding touch time measurements for welding and drilling were validated. By undertaking these recommendations, it was felt that HEV would continue to be wepositioned to capture the predicted ongoing growth in the mining market in which they currently operate, and to fully benefit from the future upturn in the energy market. / Thesis (M.B.A.)--North-West University, Potchefstroom Campus, 2012.

More people living with HIV/AIDS reside in South Africa than any other country in the world, and the nation faces colossal challenges in broadening its response to the now-mature and widespread HIV epidemic (WHO, 2005:1). According to South Africa's Medical Research Council, HIV/AIDS has now become the single largest cause of death in South Africa (Dorrington et a/., 2001:6) and has triggered a prominent transferal in the pattern of mortality from the elderly to the young, particularly among young women (Dorrington, 2001:4). The routine treatment of HIV/AIDS with antiretroviral drugs has transformed HIV-infection from an unvaryingly rapidly terminal illness to a somewhat expensive treatable, chronic disease. Triple therapy or highly active antiretroviral therapy (three-drug combinations of ARVs or HAART) in particular have had paramount impacts on HIV-related morbidity and mortality in settings where these drugs are generally accessible. Objectives of ARV treatment are "maximum, durable suppression of viral load, restoration and/or preservation of immune function, improvement of quality of life and reduction of HIV related morbidity and mortality" (Martinson et a/., 2003:236; Martinez et a/., 2007:251; Hellinger, 2006:1; Kumarasamy, 2004:3). The Joint United Nations Programme on HIV/AIDS (UNAIDS) estimated that a total of 111 827 South Africans were accessing free antiretroviral treatment in the 200 public health sector facilities across 53 districts and a further 60 000 via the private sector by late December 2005 (UNAIDS, 2005:1). The objective of this study was to review, analyse and interpret the usage and prescribing patterns of antiretroviral drugs in a section of the South African private health care sector for the period 1 January 2005 to 31 December 2006 by utilising a medicine claims database of a pharmacy benefit management company, and to investigate the costs associated with these drugs by performing a quantitative, retrospective drug utilisation review. It was found that the prevalence as well as the total medicine cost of ARV medicine items had increased during the study period but the average number of ARV medicine items per prescription as well as both the average cost per ARV medicine item and the average cost per ARV prescription decreased during the study period. Original innovator ARV medicine items and original ARV medicine items with no generic were found to be relatively expensive in comparison with ARV medicine items in general. Conversely, generic ARV medicine items were ascertained to be relatively inexpensive with reference to ARV medicine items in general. It was perceived that the average cost of ARV medicine items and prescriptions for both genders decreased from 2005 to 2006, while there was an increase in the prevalence of medicine items and prescriptions claimed for both female and male patients. The prevalence and cost of all types of ARV medicine items were found to be higher for female patients in general. It was also established that the prevalence of patients receiving antiretroviral treatment in the private health care sector peaks at the age of >30 to 244 years, in comparison with the lower age of >25 to 239 years in the public health care sector. ARV medicine items claimed for patients in the age group >35 to 239 years represented the highest percentage of the total medicine cost incurred during both study years for all ARV medicine types. The majority of ARV medicine items were prescribed by general medical practitioners, and most ARV medicine items were dispensed by community or private institutional pharmacies. It was determined that combinations of 2NRTI + NNRTI were prescribed with the highest frequency, which is compliant with traditional HAART or 'triple therapy' regimens. Lastly, it was found that none of the top 20 prescriptions for one, two and six ARV medicine items were compliant with the National Antiretroviral Treatment (ART) Guidelines. The majority of the top 20 prescriptions for three ARV medicine items (92.67 per cent during 2005 and 89.94 per cent during 2006) were compliant with the National ART Guidelines. Finally, less than half of the top 20 prescriptions for four ARV medicine items (49.60 per cent during 2005 and 36.11 per cent during 2006) were compliant with the National ART Guidelines. Only 5.56 per cent and 3.92 per cent of the top 16 prescriptions for five ARV medicine items were compliant with the National ART Guidelines during the two study years respectively / Thesis (M. Pharm. (Pharmacy Practice))--North-West University, Potchefstroom Campus, 2009.

Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for systemic control of acute and chronic pain and inflammation (Lin et ah, 2000:1129), but usage problems and side-effects that occur during the post-marketing phase of these drugs are well documented (Thiefin & Beaugerie, 2005:287). Following the demonstration of the value of anti-inflammatory therapy in diseases like rheumatoid arthritis (Boardman & Dudley Hart, 1967:268), new NSAIDs appeared on the market (Dieppe et al., 2004:867), and the indications steadily broadened from inflammatory diseases to almost any painful condition. Studies have indicated that NSAID-associated serious upper gastro-intestinal (GI) adverse events result in 103 000 hospitalisations (Bombardier, 2002:4) and 165 000 deaths per year in the United States. A study in South Africa in 2002 indicated that NSAID utilisation contributed considerably to the total cost of all medicine items from a medicine claim database in the private health care sector (Joubert, 2002:260). The objective of this study was to determine the prevalence and cost of non-steroid anti-inflammatory drugs in a section of the private health care sector, and specifically to determine the prevalence, usage and cost of Coxib (Specific cyclo-oxygenase-2 inhibitor) medicine items before and after the withdrawal of Vioxx® from the market in September 2004 (Merck, 2004). Data from two medicine claim databases for the years 2004, 2005 and 2006 (medicine claim database I) and the years 2005 and 2006 (medicine claim database M), were analysed by means of a retrospective drug utilisation review (DUR) study. The usage of Coxib medicine items was determined, and compared for the periods before and after the withdrawal of Vioxx® in September 2004. It was found that between 9 and 10.5 per cent of prescriptions dispensed through both medicine claim database I and medicine claim database M during the study period were NSAID prescriptions. NSAID medicine items on medicine claim database I represented between 3.9 % (R25 942 986) and 2.9 % (R8 073 034) of the total cost of all medicine items claimed from 2004 to 2006. NSAIDs represented 3.1 % (R58 290 412) and 2.8 % (R57 752 267) of the cost of all medicine items claimed through medicine claim database M during 2005 and 2006 respectively, indicating similar trends in the two medicine claim databases. The prevalence of Coxibs on medicine claim database I decreased from almost 20 % (47 938) in 2004 to 8.4 % (13 276) in 2005, but showed an increase again to 10.9 % (12 355) in 2006. The prevalence of both cyclo-oxygenase (COX) inhibitors, and Coxibs demonstrated a change during 1 September 2004 to 31 December 2004 when COX-inhibitors showed an increase in use, while Coxibs showed and almost equal but opposite trend with a decrease in use. This could possibly be related to perceptions of providers and public with regard to Coxibs and their related safety after the withdrawal of Vioxx® on 30 September 2004 (Merck, 2004) and other Coxibs such as Bextra® (FDA, 2005) in 2005 in USA. It is concluded that most patients who were using Coxibs before the withdrawal of Vioxx®, substituted Coxibs for COX-inhibitors, that are known for their possible gastro-intestinal side-effects. Recommendations for future research regarding NSAID use were also made, and included an investigation of the usage of Coxibs in different age groups, as well as the combination of NSAIDs with gastro-protective medicines in long-term use. / Thesis (M.Pharm. (Pharmacy Practice))--North-West University, Potchefstroom Campus, 2009.

THE UTILISATION OF LIFE MAPS AS AN AID IN FOSTER CARE SERVICE DELIVERY. During the past few years there has been a significant increase in foster care service delivery, partially due to the HIV and AIDS pandemic. More children need to be placed in foster care, and family placements become an only option in many cases. Due to this shift in foster care placements permanency planning has become an important part of foster care services. Thus, this study has focused on the development of guidelines by using a concept model with the focus on life maps in order to facilitate and structure the foster care process. / Thesis (M.A. (MW))--North-West University, Potchefstroom Campus, 2009.

This study focuses on optimising operations effectiveness and capacity at a heavy engineering plant, namely Heavy Engineering Vereeniging, a division of DCD–DORBYL (Pty) Ltd. The implementation and adoption of technology was included in the investigation. The company operates from 2 premises in Vereeniging and Vanderbijlpark (Gauteng), and consists of 5 factory buildings. A literature review was conducted to ascertain current industry best practises and technology implementation initiatives. This review included a discussion on the following aspects: Capacity and its utilisation, flexible technology and advanced manufacturing systems, technology in manufacturing, capacity expansion and scheduling, factory layouts, technology and capacity utilisation in a South African context, and finally future trends in capacity and technology at Heavy Engineering Vereeniging. Data collection from within the organisation was done via the issuing of a questionnaire and conducting interviews with various management and supervision employees. The gathered data was analysed for employees’ opinions on current utilisation of capacity and use of technology, as well as suggestions regarding improved working methods, factory layout and the implementation of new technology. The quantitative data was analysed using the Statistical Package for the Social Sciences software, with the provided descriptive statistical test results used for the identification of possible trends and further interpretation. It was found that current capacities and equipment are being well utilised, but not to their optimal level. The well entrenched management information systems, measurement systems and operating procedures currently in use will aid to increase the level of utilisation of the available capacity and equipment. The implementation of technology and latest best practises within the operation will gain HEV a competitive edge, ensuring their future sustainability and market leadership. However, this implementation must be done with the input and buy in of the work force. The variances in perceptions and attitudes between the various job functions, discovered during the statistical analysis, must be taken into cognisance during any capacity optimisation or technology implementation initiative. Continued capital expenditure and the current drives in research and development need to be maintained to further ensure sustainability. Various inefficiencies were identified and recommendations were made to improve the current operation’s effectiveness and factory layout, primarily by decreasing operating inefficiencies. The recommendations were made based on the results of the study and included the expenditure involved in their execution. Financially viable options, calculated using payback periods and net present values (NPV), included the purchase of phased array ultrasonic testing equipment, horizontal SAW for longitudinal flanges and a modular type furnace. Other options, which could improve operations effectiveness, but not returning financially positive results, included the moving of the Hausler roll into the main fabrication workshop and the moving of the Sachems drills to alongside the lathes. A number of new processes and initiatives were recommended, for which cost comparisons to current similar practices could not be performed. These included the full production implementation of the punch through tandem arc submerged arc welding for wind turbine tower manufacture, implementation of a customer interfacing and communication platform and internal communication display boards. Current practises regarding touch time measurements for welding and drilling were validated. By undertaking these recommendations, it was felt that HEV would continue to be wepositioned to capture the predicted ongoing growth in the mining market in which they currently operate, and to fully benefit from the future upturn in the energy market. / Thesis (M.B.A.)--North-West University, Potchefstroom Campus, 2012.

Le système canadien de soins de santé coûte cher et il a besoin d’être amélioré afin de devenir plus performant. Cette amélioration du système de soins de santé passe par une recherche innovatrice, c’est-à-dire une recherche basée sur la collaboration entre les producteurs et les utilisateurs de cette recherche. Cette collaboration favorise l’utilisation de la recherche. De nombreuses études ont démontré qu'un facteur déterminant favorise l'utilisation de la recherche: les bonnes relations interpersonnelles entre chercheurs et utilisateurs à toutes les étapes de la recherche, partant de l’identification des priorités de recherche et de l'élaboration des questions de recherche, jusqu'à la mise en œuvre des résultats. Cette thèse offre des pistes pour comprendre les attitudes et les comportements qui favorisent les bonnes relations interpersonnelles entre chercheurs et utilisateurs, ce qui servira à mettre en place des processus de transfert de connaissances efficaces qui mèneront à l'utilisation de la recherche.